Back to Agenda
SESSION 1: Middle East & North Africa Townhall
Session Chair(s)
Amira Younes
Director- Europe, Middle East & Africa (EMEA), Global Regulatory Policy, MSD, United Arab Emirates
Sara Torgal, MPharm
, European Medicines Agency (EMA), Netherlands
Overview: In this session, a representative from each Health Authority in the MENA region will share updates, developments and future plans, followed by an interactive Panel Discussion.
Speaker(s)
Overall Strategic Trends and Policy Priorities in the Middle East & Africa
Amira Younes
Director- Europe, Middle East & Africa (EMEA), Global Regulatory Policy, MSD, United Arab Emirates
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Aisha Al Ansari
Director, Pharmacy and Drug Control Department, Ministry of Public Health, Qatar, Qatar
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Donia Al Bastaki
Head of Registration Department, Pharmaceutical & Herbal Medicines Registration , Ministry of Health, Drug and Food Control, Kuwait
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Tamer El-Hossieny
Vice Chairman, Egyptian Drug Authority (EDA), Egypt
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Shatha Ziad Al-Quraan
Head - Chemical Drug Registration Department, Jordan Food and Drug Administration (JFDA), Jordan
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Nancy Yang Ngum
Public Health Officer (Public Health Expert), African Union Development Agency (AUDA-NEPAD), South Africa
Panel Discussion with Q&A (With the additional participation of):
Speaker(s) / Representative(s) Invited
, Switzerland
Have an account?